News of Pharmaceuticals | Healthcare | Wellness in Gujarat

KILITCH DRUGS will invest USD $5 mln for 2nd project in Ethiopia

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals products manufacturing company Kilitch Drugs (India) Ltd., said of gearing to invest USD $5 million  for second greenfield project in Ethiopia. In a press-release as submitted by the company to the Indian Bourses, titled – “Kilitch

Dr REDDY’s gets USFDA nod to market medicine to treat tumour

PRINCETON (NEW JERSEY – US) HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceutical company Dr Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to market medicine to treat tumour for bone-marrow and cancer and has

STRIDE PHARMA gets USFDA nod to market pain-killer medicine

BANGALORE | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered pharmaceuticals company Strides Pharma Sciences Ltd said its Singapore based step-down subsidiary company Strides Pharma Global Pte. Ltd., Singapore of having got USFDA (US Food and Drugs Administration) approval to market pain-killer medicine –

ALEOR DERMA gets USFDA nod to market medicine to treat knee pain

VADODARA (BARODA) | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of its joint-venture company Aleor Dermaceuticals having got USFDA nod to market medicine to treat knee pain. In a press-release as submitted by the company to the

SUVEN LIFE announces phase-2 studies on research of Alzheimer’s medicine

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceuticals company Suven Life Sciences Ltd said of having announced topline results of phase-2 trials for study in patients with moderate Alzheimer’s diseases. The press-release as submitted by the company to the Indian Bourses, titled

SUN PHARMA denied dismissal of certain claims in an ongoing lawsuit in US

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian Pharmaceutical major – Sun Pharmaceutical Industries Ltd said of having updated on the ongoing litigation in regards to Ranbaxy Generic Drug Application Anti-Trust litigation in US Courts, where the US District court

ALEMBIC PHARMA gets USFDA nod to sell medicine to cure Prostate Enlargement

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got nod to market medicines to treat prostate enlargement disease. In a press-release as submitted by the company to the Indian Bourses, titled – “Alembic Pharmaceuticals receives

INDOCO REMEDIES’ CRO – AnaCipher receives EIR from USFDA

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory updates submitted to the Indian Stock Exchanges, Hyderabad headquartered Indoco Remedies Ltd’s Clinical Research Organization (CRO) has been inspected by USFDA (US Food and Drugs Administration) and cleared being granted Establishment Inspection Report (EIR). In a press-release as submitted by the company to the

GLENMARK PHARMA gets USFDA nod to market medicine to treat obesity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having received USFDA (US Food and Drugs Administration) nod to market medicine to treat obesity and overweight related disorders. In a company press-release as submitted to the Indian Bourses, titled – “Glenmark

USFDA inspects INDOCO REMEDIES’ Goan plants gives EIR

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indoco Remedies Ltd said of its Goan plants inspected and having received Establishment Inspection Report (EIR). In a press-release submitted to the Indian Bourses, titled – “Indoco receives EIR for its manufacturing facilities in Goa (Plant II

LUPIN launches Hydrocortisone Valerate Cream for adult patients

BALTIMORE (US) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Lupin Ltd said of having got USFDA (US Food and Drug Administration) nod to market dermatology (skin care) product for adults. In a company press-release as submitted to the Indian Bourses –

Dr REDDY’s LABS gets USFDA nod to market medicine to treat thyroid

PRINCETON (NEW JERSEY – US) | HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Hyderabad headquartered Dr. Reddy’s Laboratories Ltd said of having got nod to market medicine to treat thyroid and launched the same product in US Markets. In a press-release as submitted by

LUPIN launches “ADHERO” smart device to support respiratory treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Lupin Ltd said of having launched first-of-its-kind smart device in India, to support treatment of respiratory disease. In a company press-release as submitted to the Indian Bourses, titled – “Lupin launches “Adhero,” first-of-its-kind connected Smart Device in

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat iron levels in blood

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Vaoddara headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of having got nod to market medicine to treat iron levels in blood, especially to treat chronic iron overload due to blood transfusions in patients of

CADILA HEALTH (ZYDUS) gets USFDA nod to market medicine for cardiac cure & skin treatment

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel lead Zydus Cadila Group) said of having got nod from USFDA (US Food & Drugs Administration) to market medicines to cure cardiac problems and skin-treatment. In a press-release as submitted by

CADILA HEALTH (ZYDUS) announces 2nd Phase-3 trials for a nephrology product

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Group) announced second phase-3 trials of Desidustat, medicine used to treat patients with kidney disease and kidney related disorders. In a press-release as submitted by the company to the

Do NOT follow this link or you will be banned from the site!